| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/28/2011 | CA2784814A1 Heterodimer binding proteins and uses thereof |
| 07/28/2011 | CA2784807A1 Type ii raf kinase inhibitors |
| 07/27/2011 | EP2348134A1 RNA interference mediating small RNA molecules |
| 07/27/2011 | EP2348133A1 RNA interference mediating small RNA molecules |
| 07/27/2011 | EP2348119A2 Multicistronic lentiviral vector |
| 07/27/2011 | EP2348118A1 A polynucleotide comprising a ubiquitous chromatin opening element (ucoe) |
| 07/27/2011 | EP2348104A1 Multipotent adult stem cells and methods for isolation |
| 07/27/2011 | EP2348048A1 Antagonistic Anti-HTNFSF13B Human Antibodies |
| 07/27/2011 | EP2348045A1 Receptor, use of same and murine antibody |
| 07/27/2011 | EP2348043A1 APO-2 ligand variants and uses thereof |
| 07/27/2011 | EP2348031A2 17-Alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as antiprogestational agents |
| 07/27/2011 | EP2348030A2 17-Alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as antiprogestational agents |
| 07/27/2011 | EP2348024A2 Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents |
| 07/27/2011 | EP2348023A1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors |
| 07/27/2011 | EP2348021A1 Rotaxane compound and antitumor agent |
| 07/27/2011 | EP2347771A1 Peptide-based compounds for targeted imaging |
| 07/27/2011 | EP2347770A2 Process for producing an injectable pharmaceutical preparation |
| 07/27/2011 | EP2347767A2 Immune regulation based on the targeting of early activation molecules |
| 07/27/2011 | EP2347766A1 Use of TNFalpha antibodies and another drug |
| 07/27/2011 | EP2347761A1 A composition with inhibition activity on pathological angiogenesis |
| 07/27/2011 | EP2346904A1 Methods and agents for the diagnosis and treatment of hepatocellular carcinoma |
| 07/27/2011 | EP2346903A1 Treatment with anti-alpha2 integrin antibodies |
| 07/27/2011 | EP2346896A1 Etoposide and doxorubicin conjugates for drug delivery |
| 07/27/2011 | EP2346881A1 Novel compounds which modulate kinase activity |
| 07/27/2011 | EP2346876A1 Novel 4beta-amino podophvllotoxin congeners as anti tumour antibiotics a process for the preparation thereof |
| 07/27/2011 | EP2346875A1 Metalloporphyrin derivatives, nanoparticles comprising the same, and use thereof for photodynamic therapy |
| 07/27/2011 | EP2346874A1 Process for preparing chlorins and their pharmaceutical uses |
| 07/27/2011 | EP2346871A1 Alpha helix mimetics in the treatment of cancer |
| 07/27/2011 | EP2346867A1 Phosphodiestarase inhibitors |
| 07/27/2011 | EP2346859A1 Heterocyclic jak kinase inhibitors |
| 07/27/2011 | EP2346856A1 2-[1h-benzimidazol-2(3h)-ylidene]-2-(pyrimidin-2-yl)acetamides and 2-[benzothiazol-2(3h)-ylidene]-2-(pyrimidin-2-yl)acetamides as kinase inhibitors |
| 07/27/2011 | EP2346852A1 Pyrrolidin-2-ones as hdm2 ligands |
| 07/27/2011 | EP2346829A1 Inhibitors of stat3 |
| 07/27/2011 | EP2346827A1 Pyridine derivatives as vegfr-2 receptor and protein tyrosine kinase inhibitors |
| 07/27/2011 | EP2346818A2 Substituted sulphonamido phenoxybenzamides |
| 07/27/2011 | EP2346531A2 Tumor vaccine |
| 07/27/2011 | EP2346526A2 Compositions of and methods of using ligand dimers |
| 07/27/2011 | EP2346524A2 New therapy and medicament using integrin ligands for treating cancer |
| 07/27/2011 | EP2346514A1 Medium derived from stem cells as a pharmaceutical composition |
| 07/27/2011 | EP2346508A1 Heterocyclic kinase inhibitors |
| 07/27/2011 | EP2346499A1 Smoothened antagonism for the treatment of hedgehog pathway-related disorders |
| 07/27/2011 | EP2346497A1 Compound for local deletion of tumors |
| 07/27/2011 | EP2346491A1 Novel pharmaceutical uses for nanoparticles |
| 07/27/2011 | EP2346427A1 Methods for improved cryo-chemotherapy tissue ablation |
| 07/27/2011 | EP1951697B1 Substituted 5-phenyl-3,6-dihydro-2-oxo-6h-[1,3,4]thiadiazines |
| 07/27/2011 | EP1948617B1 Pyrimidinones as casein kinase ii (ck2) modulators |
| 07/27/2011 | EP1866302B1 Pyrazole derivatives |
| 07/27/2011 | EP1638964B1 Novel compounds that modulate ppar-gamma type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 07/27/2011 | EP1634881B1 Harmine derivatives, intermediates used in their preparation, preparation processes and use thereof |
| 07/27/2011 | EP1633396B1 Cd20 binding molecules |
| 07/27/2011 | EP1601646B1 2-substituted vitamin d analogues and their therapeutic uses |
| 07/27/2011 | EP1587550B1 Methods and compositions for administering therapeutic and diagnostic agents |
| 07/27/2011 | EP1558645B1 Stabilized single domain antibodies in pharmaceutical composition adapted for inhalation |
| 07/27/2011 | EP1534284B1 Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders |
| 07/27/2011 | EP1490355B1 Indolylmaleimide derivatives |
| 07/27/2011 | EP1443928B1 Treatment of neurodegenerative diseases and cancer of the brain |
| 07/27/2011 | EP1435993B1 Utilisation d'une proteine de la famille des crmps pour le traitement des maladies liees au systeme immunitaire |
| 07/27/2011 | EP1366062B1 Efficient recovery of correctly refolded proteins |
| 07/27/2011 | EP1351694B2 Promoting cell regeneration and/or cell differentiation with non-metabolizable sugar and a polymeric absorbent |
| 07/27/2011 | EP1071805B1 Adenoviral vectors for treating disease |
| 07/27/2011 | EP1011743B1 Loading and release of water-insoluble drugs |
| 07/27/2011 | CN1984899B CXCR1 and CXCR2 chemokine antagonists |
| 07/27/2011 | CN1966684B Construction of HER2/neu mRNA in vitro transcription vector and use thereof |
| 07/27/2011 | CN1964979B Novel water-soluble prodrug |
| 07/27/2011 | CN1935228B Chinese medicine composition for preventing and treating breast cancer and its preparation method |
| 07/27/2011 | CN1823748B Medicinal preparation of coenzyme Q10 liposome and its preparation technology |
| 07/27/2011 | CN1309666B Polymer composition of glucuronic acid glucosan |
| 07/27/2011 | CN102137929A Anti-CDH3 antibodies labeled with radioisotope label and uses thereof |
| 07/27/2011 | CN102137925A Method for simultaneous induction of CTL and [gamma][delta]t cell |
| 07/27/2011 | CN102137873A Anti-CD5 antibodies |
| 07/27/2011 | CN102137863A Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |
| 07/27/2011 | CN102137860A Compositions with and process for methylmorpholin -subsituted pyrido [2, 3-D] pyrimidines |
| 07/27/2011 | CN102137859A Imidazopyridine derivatives as inhibitors of receptor tyrosine kinases |
| 07/27/2011 | CN102137856A 2,4'-bipyridinyl compounds as protein kinase D inhibitors useful for the treatment of IA heart failure and cancer |
| 07/27/2011 | CN102137854A 4-(pyridin-4-yl)-1H-[1,3,5]triazin-2-one derivatives as GSK3-beta inhibitors for the treatment of neurodegenerative diseases |
| 07/27/2011 | CN102137849A Cyclic polyamines for binding phosphatidylserine |
| 07/27/2011 | CN102137847A Bicyclic heterocycles as MEK kinase inhibitors |
| 07/27/2011 | CN102137846A N-(2-aminophenyl)-4-[N-(pyridine-3-yl)-methoxycarbonyl-aminomethyl]-benzamide (MS-275)polymorph b |
| 07/27/2011 | CN102137843A Isoindolone derivatives as MEK kinase inhibitors and methods of use |
| 07/27/2011 | CN102137679A Isolation of cyclopamine |
| 07/27/2011 | CN102137678A Process for extraction of glucosinolate s from broccoli seeds |
| 07/27/2011 | CN102137674A Synthesis and formulations of salts of isophosphoramide mustard and analogs thereof |
| 07/27/2011 | CN102137666A Chemical compounds 251 |
| 07/27/2011 | CN102137660A Detection and use of low molecular-weight modulators of the cold-menthol receptor TRPM8 |
| 07/27/2011 | CN102134284A Anti-hepatoma drug strongylocentrotus nudus egg polysaccharide SEP-1 based on immune regulation |
| 07/27/2011 | CN102134277A Soluble VEGFR (Vascular Endothelial Growth Factor Receptor) difunctional chimera receptor VEGFR31-Ig as well as preparation method and application thereof |
| 07/27/2011 | CN102134276A Chimeric antibody resisting CTLA-4 (Cytotoxic T Lymphocyte Antigen) |
| 07/27/2011 | CN102134275A 表皮生长因子受体变异体 Epidermal growth factor receptor variant |
| 07/27/2011 | CN102134246A Epothilone derivatives as well as preparation and medicament application thereof |
| 07/27/2011 | CN102134245A Tetralin isoquinoline compounds as well as preparation methods and applications thereof |
| 07/27/2011 | CN102134244A Medical photosensitizer and preparation method thereof |
| 07/27/2011 | CN102134243A Bicyclic amino pyrazole derivatives with anti-tumor activity |
| 07/27/2011 | CN102134234A Indazolyl urea compounds and preparation method and medicinal use thereof |
| 07/27/2011 | CN102134231A Dipeptidyl peptidase inhibitors |
| 07/27/2011 | CN102134230A Dipeptidyl peptidase inhibitors |
| 07/27/2011 | CN102134229A Dipeptidyl peptidase inhibitors |
| 07/27/2011 | CN102134220A 9-amsacrine derivatives as well as preparation method and application thereof |
| 07/27/2011 | CN102134218A 6-aryl amino pyridone sulfamide and 6-aryl amino pymetrozine sulfamide methyl ethyl ketone (MEK) inihibitor |
| 07/27/2011 | CN102134207A Urea compound and preparation method and application thereof |
| 07/27/2011 | CN102134188A Tetrahydroanthraquinone compound Prisconnatacin and preparation method and application thereof in preparation of anti-tumor medicaments |